Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.6960
-0.0341 (-4.67%)
At close: Jun 5, 2026, 4:00 PM EDT
0.6971
+0.0011 (0.16%)
After-hours: Jun 5, 2026, 6:40 PM EDT
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $4.58 million as of June 5, 2026. Its market cap has increased by 99.16% in one year.
Market Cap
4.58M
Enterprise Value
-13.58M
1-Year Change
99.16%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $4.58M, a decrease of -96.86%. That is a compound annual growth rate of -24.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 4.60M | 12.20% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 5.35M |
| TransCode Therapeutics | 5.32M |
| Mustang Bio | 5.08M |
| Matinas BioPharma Holdings | 5.05M |
| Pulmatrix | 4.86M |
| GeoVax Labs | 4.77M |
| Dermata Therapeutics | 4.75M |
| Soligenix | 4.57M |